Date Filed | Type | Description |
02/27/2023 |
4
| Bernstein Karen (Director) has filed a Form 4 on Ovid Therapeutics Inc.
Txns:
| Granted 15,000 options to buy
@ $2.5, valued at
$37.5k
|
|
06/21/2022 |
4
| Bernstein Karen (Director) has filed a Form 4 on Codiak BioSciences, Inc.
Txns:
| Granted 7,500 options to buy
@ $2.83, valued at
$21.2k
Granted 1,500 restricted stock units
@ $0 |
|
04/12/2022 |
4
| Bernstein Karen (Director) has filed a Form 4 on Ovid Therapeutics Inc.
Txns:
| Granted 69,424 options to buy
@ $3.22, valued at
$223.5k
|
|
02/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/04/2022 |
4
| Bernstein Karen (Director) has filed a Form 4 on Ovid Therapeutics Inc.
Txns:
| Granted 15,000 options to buy
@ $2.72, valued at
$40.8k
|
|
06/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/11/2021 |
4
| Bernstein Karen (Director) has filed a Form 4 on Ovid Therapeutics Inc.
Txns:
| Granted 15,000 options to buy
@ $4.49, valued at
$67.4k
|
|
05/18/2021 |
4
| Bernstein Karen (Director) has filed a Form 4 on Ovid Therapeutics Inc.
Txns:
| Granted 1,750 options to buy
@ $3.67, valued at
$6.4k
|
|
10/15/2020 |
4
| Bernstein Karen (Director) has filed a Form 4 on Codiak BioSciences, Inc.
Txns:
| Granted 10,000 options to buy
@ $15, valued at
$150k
|
|
10/13/2020 |
3
| Bernstein Karen (Director) has filed a Form 3 on Codiak BioSciences, Inc. |
06/08/2020 |
4
| Bernstein Karen (Director) has filed a Form 4 on Ovid Therapeutics Inc.
Txns:
| Granted 13,250 options to buy
@ $5.29, valued at
$70.1k
|
|
11/15/2019 |
4
| Bernstein Karen (Director) has filed a Form 4 on Ovid Therapeutics Inc.
Txns:
| Granted 7,437 options to buy
@ $2.43, valued at
$18.1k
|
|
08/01/2019 |
4/A
| Bernstein Karen (Director) has filed a Form 4 on Ovid Therapeutics Inc.
Txns:
| Granted 5,813 options to buy
@ $1.65, valued at
$9.6k
|
|
06/10/2019 |
4
| Bernstein Karen (Director) has filed a Form 4 on Ovid Therapeutics Inc.
Txns:
| Granted 5,813 options to buy
@ $1.6, valued at
$9.3k
|
|
02/28/2019 |
4
| Bernstein Karen (Director) has filed a Form 4 on Ovid Therapeutics Inc.
Txns:
| Bought 10,000 shares
@ $2.021, valued at
$20.2k
|
|
08/16/2018 |
4
| Bernstein Karen (Director) has filed a Form 4 on Ovid Therapeutics Inc.
Txns:
| Bought 10,000 shares
@ $6.23, valued at
$62.3k
|
|
06/08/2018 |
4
| Bernstein Karen (Director) has filed a Form 4 on Ovid Therapeutics Inc.
Txns:
| Granted 5,813 options to buy
@ $8.12, valued at
$47.2k
|
|
06/07/2018 |
4
| Bernstein Karen (Director) has filed a Form 4 on Achaogen Inc
Txns:
| Granted 15,000 options to buy
@ $12.07, valued at
$181.1k
|
|
07/13/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/13/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
05/04/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
10/25/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
05/27/2016 |
4
| Bernstein Karen (Director) has filed a Form 4 on Vitae Pharmaceuticals, Inc
Txns:
| Granted 10,000 options to buy
@ $9.62, valued at
$96.2k
|
|